| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.5 |